Fitchburg, WI, United States of America

Eugene J McNally

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Eugene J McNally

Introduction

Eugene J McNally is a notable inventor based in Fitchburg, WI (US). He has made significant contributions to the field of ophthalmic formulations, holding a total of three patents. His work focuses on the development of topical cyclosporine-containing formulations, which have important applications in treating ocular diseases.

Latest Patents

One of McNally's latest patents is for topical cyclosporine-containing formulations and their uses. This patent details formulations for topical ophthalmic applications that contain 0.087-0.093 wt % of cyclosporine. The formulations may include a polyoxyl lipid or fatty acid, and/or a polyalkoxylated alcohol, and may also incorporate nanomicelles. These formulations are designed to treat or prevent various ocular diseases or conditions.

Career Highlights

Throughout his career, Eugene J McNally has worked with prominent companies in the pharmaceutical industry, including Sun Pharma Global Fze and Sun Pharmaceutical Industries Limited. His expertise in developing innovative formulations has positioned him as a key figure in his field.

Collaborations

McNally has collaborated with notable professionals such as Sidney L Weiss and Ashim K Mitra. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Eugene J McNally's contributions to the field of ophthalmic formulations through his innovative patents highlight his role as a significant inventor. His work continues to impact the treatment of ocular diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…